Menu

Recent Interviews

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


12. November 2019 | 06:36 CET

AURORA, BEVCANNA, CANOPY OR EXMCEUTICALS - WHICH CANNABIS SHARE HAS POTENTIAL?

  • Cannabis
Photo credits: pixabay.com

The shares of Canadian cannabis companies have lost significant value this year. There are exceptions, such as BevCanna and EXMceuticals, but the well-known players such as Aurora and Canopy have fallen significantly. This was preceded by a period of price rises and forecasts that never seemed to end. In the meantime, the phase of speculation is over and it is all about facts. Speculators go out and investors stand on the sidelines and observe the development or already use the chance to enter.

time to read: 1 minutes by Mario Hose
ISIN: CA05156X1087


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


AURORA SHARE LOST MORE THAN 60%.

The shares of Aurora and Canopy have lost significant value this year. The shares of Aurora changed hands this year at the top of the Canadian home stock exchange at CAD 13.67. The shares of Aurora have lost a lot of value this year. On yesterday's trading day, the stock was sold at 4.78 CAD. The low for the year so far was 4.58 CAD. At the peak of the hype in 2018, the share was still listed at CAD 16.74. The current market value is CAD 4.88 billion.

WHEN WAS THE BOTTOM FOUND AT CANOPY?

The development is similar for the industry giant Canopy. The company's shares peak in 2019 at 70.99 CAD. In the previous year even a price of 76.68 CAD was reached. Size also does not protect this title from a price correction and in the meantime the share is listed close to the low for the year of 25.00 CAD. Yesterday, the share was sold at 26.85 CAD. Canopy's market value has thus shrunk to CAD 9.35 billion.

STOCK EXCHANGE DEBUTANTS OFFER ALTERNATIVE

Meanwhile, the situation at BevCanna and EXMceuticals looks more relaxed, but this is certainly also due to the size of the two companies. BevCanna is a producer of cannabis drinks and, like CBD producer EXMceuticals, celebrated its stock market debut this year. The two companies were thus spared the hype in 2018 and the share price trend is thus calmer - without massive setbacks. The company value of BevCanna amounts to about 20.93 million CAD with a share price of 0.44 CAD.

At yesterday's closing price of CAD 1.00, EXMceuticals reported a stock market value of CAD 36.55. The company's share price was around CAD 20.93 million. Jonathan Summers is Chairman of EXMceuticals and will present the company to investors at this year's German Equity Forum of Deutsche Börse AG in Frankfurt from 25 to 27 November 2019.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

28. October 2021 | 12:04 CET | by André Will-Laudien

Canopy, Tilray, Sativa Wellness, Formycon - Finding the next cannabis rocket!

  • Cannabis

The big bull market in cannabis ran through 2018 and 2019, and then in 2020, the reality set in that only a fraction of states around the world will implement general licensing for hemp. The newly elected federal parliament has its first constituent session these days. Climate change and investments in digital infrastructure are two of the most important topics in the coalition negotiations to form a new federal government. One topic that is not quite so high on the list of priorities, but is already causing a lot of excitement in the run-up, is the possible legalization of cannabis. The Greens and FDP have been advocating legal, regulated trade for some time. Of course, nothing has been decided yet, but the outgoing federal government's drug commissioner, Daniela Ludwig of the CSU, already warns of the consequences. We take a look at important industry representatives.

Read

26. October 2021 | 11:37 CET | by Stefan Feulner

Tilray, Ayurcann, Aurora Cannabis, Canopy Growth - Sow first, then reap

  • Cannabis

After the hype around cannabis companies like Aurora Cannabis, Tilray and Canopy Growth in 2018, consolidation followed, and it continues. But the industry is moving mightily. Smaller companies disappeared from the price list, while big players expanded their market power through mergers and acquisitions for the next few years. The cannabis industry is predicted to grow tremendously in the future. The fantasy is fueled by government legalization plans in several states, including Germany.

Read

04. March 2021 | 09:16 CET | by Stefan Feulner

NanoRepro, EXMceuticals, Deutsche Telekom - The profiteers of the new world!

  • Cannabis

The world has changed since last year. The goal is to fight and contain the virus, which has destroyed our everyday life. In addition to the vaccine manufacturers such as BioNTech, AstraZeneca or Moderna, there are more and more new winners emerging from nowhere to become new stock market stars. Currently, the dominant topic, apart from the vaccination programs that are still hardly taking place in Germany, is the "national testing strategy." At the very least, this should enable a more regular and open life. Be there!

Read